banner2

Getting started
6-Boc-Hydrazinonicotinic Acid CAS 133081-25-1

6-Boc-Hydrazinonicotinic Acid CAS 133081-25-1 - Manufacturers, Factory, Suppliers from China

6-Boc-Hydrazinonicotinic Acid CAS 133081-25-1, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

6-Boc-Hydrazinonicotinic Acid 6-Boc-Hynic CAS 133081-25-1 Purity 98.5 (HPLC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 6-Boc-Hydrazinonicotinic Acid CAS 133081-25-1 Purity >98.5% (HPLC)
Read More

N-Acetylneuraminic Acid CAS 131-48-6 Assay ≥98.0% (HPLC)

(R)-3-Aminobutanoic Acid Hydrochloride CAS 58610-42-7 Assay ≥98.0% (HPLC)

1-Naphthaleneacetic Acid CAS 86-87-3 Assay ≥98.0% (GC) Factory

Pyrrole-3-Carboxylic Acid CAS 931-03-3 Purity >98.0% (GC)

Benzylboronic Acid CAS 4463-42-7 Purity ≥98.0% (HPLC)

H-Glu-OtBu CAS 45120-30-7 L-Glutamic Acid α-tert-Butyl Ester Purity >99.0% (HPLC)

banner4

Top Selling Products

Related Blog
Reviews

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...

2022.02.08 06:52:31
2022.01.26 16:54:40
2022.01.11 21:47:59
2021.12.23 09:46:57
2021.12.02 15:01:40
2021.11.13 16:40:22

related search